Denmark · Funded startup

Who invested in ExpreS2ion

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$1.3Mraised across 1 round since 2025, from 1 source

Latest round
Round, $1.3MOct 2025
Investors
2
See who backed them

The rounds

  1. Oct 2025
    Round$1.3M

    Source recorded

Founders and team

From ExpreS2ion's own website: 8 on the team.

  • Bent U. FrandsenChief Executive Officer
  • Egalet Ltd.Other material ongoing positions : CEO of ViroGates
  • Dr. Max M. SøgaardChief Scientific Officer
  • Keith AlexanderChief Financial Officer
  • Dr. Karin GarreBoard Member
  • Dr. Martin Roland JensenChairman
  • Jakob KnudsenBoard Member
  • Michel BaijotBoard Member

AdvisersDr. Mark Schleiss

Everyone who backed them

Horizon 2020VC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ExpreS2ion

Who invested in ExpreS2ion?

ExpreS2ion's investors include Horizon 2020 and Innovation Fund Denmark.

How much has ExpreS2ion raised?

ExpreS2ion has raised $1.3M across 1 round since 2025.

When did ExpreS2ion last raise?

ExpreS2ion's most recent round was an Undisclosed round of $1.3M in Oct 2025.

What was ExpreS2ion's biggest round?

Its most recent round, $1.3M in Oct 2025, is also its largest on record.

Who backed ExpreS2ion first?

ExpreS2ion's first round on record, in Oct 2025, was backed by Horizon 2020 and Innovation Fund Denmark.

What stage is ExpreS2ion at?

ExpreS2ion's latest named round is an Undisclosed round, in Oct 2025.

Where is ExpreS2ion based?

ExpreS2ion is based in Denmark.

Companies like ExpreS2ion

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.